Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer
Clinical trial NCT03509298 · WITHDRAWN
Trial details
- NCT number
- NCT03509298
- Sponsor
- Fuda Cancer Hospital, Guangzhou
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2020-05-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.